The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis
Abstract
Hereditary hemochromatosis is a prevalent genetic disorder of iron hyperabsorption leading to hyperferremia, tissue iron deposition and complications including cirrhosis, hepatocarcinoma, cardiomyopathy and diabetes. Most individuals affected with hereditary hemochromatosis are homozygous with respect to a missense mutation that disrupts the conformation of HFE, an atypical HLA class I molecule (ref. 1; OMIM 235200). Mice lacking Hfe or producing a C282Y mutant Hfe protein develop hyperferremia and have high hepatic iron levels. In both humans and mice, hereditary hemochromatosis is associated with a paucity of iron in reticuloendothelial cells. It has been suggested that HFE modulates uptake of transferrin-bound iron by undifferentiated intestinal crypt cells, thereby programming the absorptive capacity of enterocytes derived from these cells; however, this model is unproven and controversial. Hepcidin, a peptide hormone (HAMP; OMIM 606464), seems to act in the same regulatory pathway as HFE. Although expression of mouse Hamp is normally greater during iron overload, Hfe-/- mice have inappropriately low expression of Hamp. We crossed Hfe-/- mice with transgenic mice overexpressing Hamp and found that Hamp inhibited the iron accumulation normally observed in the Hfe-/- mice. This argues against the crypt programming model and suggests that failure of Hamp induction contributes to the pathogenesis of hemochromatosis, providing a rationale for the use of HAMP in the treatment of this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, transgenic expression of hepcidin prevented iron overload in Hfe−∕− (Nicolas et al., 2003) and Hbbth3∕+ (Gardenghi et al., 2010) mice, models of HH and β-thalassemia intermedia, respectively.”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Nicolas et al., 2003
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · cited 1×
“It is synthesized predominantly in the liver, secreted as peptides of 20–25 amino acid”
BackgroundHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Self-citationNicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Self-citationSevere iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860
Weinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood · doi:10.1182/blood-2002-04-1260 · Cited by 632
Self-citation
Cited by
Items 101–200 of 310
NRF2 and Hypoxia-Inducible Factors: Key Players in the Redox Control of Systemic Iron Homeostasis
Duarte, T. L., Talbot, N. P., & Drakesmith, H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8148 · Cited by 78
“Inappropriately low hepcidin expression is a feature of both mouse models and human patients with HFE-related hemochromatosis (2, 14, 111, 119).”
Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans
Lehtihet, M., Bonde, Y., Beckman, L., Berinder, K., Höybye, C., Rudling, M. J., Sloan, J. H., Konrad, R. J., & Angelin, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148802 · Cited by 78
“This is because hemochromatosis patients with inactivating mutations in the hepcidin gene (HAMP), and mice with disruption of the hepcidin gene expression do not display a polycythemic phenotype [20, 21].”
BackgroundHepcidin: A novel peptide hormone regulating iron metabolism
Singh, B., Arora, S., Agrawal, P., & Gupta, S. K. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.02.014 · Cited by 61
Mok, H., Jelinek, J., Pai, S., Cattanach, B. M., Prchal, J. T., Youssoufian, H., & Schumacher, A. (2004) · Development · doi:10.1242/dev.01081 · Cited by 73
“…balance in murine models of Hampgain- and loss-of-function (Nicolas et al., 2001; Nicolas et al., 2002a), as well as failure of Hamp induction in a murine model for HFE hemochromatosis (Ahmad et al., 2002; Nicolas et al., 2003) reveal Hamp as the principal hormonal regulator of iron homeostasis.”
BackgroundInfluentialSiah, C. W., Trinder, D., & Olynyk, J. K. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.02.022 · Cited by 95
Aguilar‐Martinez, P., Schved, J., & Brissot, P. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40998.x · Cited by 73
“Finally, hepcidin is considered a candidate molecule for the treatment of iron overload (58).”
BackgroundKupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression
Theurl, M., Theurl, I., Hochegger, K., Obrist, P., Subramaniam, N., van Rooijen, N., Schuemann, K., & Weiss, G. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0346-y · Cited by 69
Herrmann, T., Muckenthaler, M., van der Hoeven, F., Brennan, K., Gehrke, S. G., Hubert, N., Sergi, C., Gröne, H.-J., Kaiser, I., Gosch, I., et al. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0508-x · Cited by 69
“Rather, a hepatic regulatory defect causing misexpression of hepcidin may underlie the duodenal hyperabsorption of iron [32, 33, 34, 35, 36].”
BackgroundModulation of iron homeostasis in macrophages by bacterial intracellular pathogens
Pan, X., Tamilselvam, B., Hansen, E. J., & Daefler, S. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-64 · Cited by 69
“Hepcidin thus effectively reduces iron efflux [39-41].”
Makui, H., Soares, R., 蒋文雷, Constante, M., & Santos, M. M. (2005) · Blood · doi:10.1182/blood-2005-02-0629 · Cited by 70
“constitutive hepcidin expression in the liver is sufficient to prevent iron accumulation normally observed in Hfe mice.(57) A clue to how hepcidin, in turn, may regulate iron absorption is provided by the recent finding that it can bind to Fp1, the major cellular iron exporter protein, inducing Fp1 internalization and…”
BackgroundSang, Y., Ramanathan, B., Minton, J. E., ROSS, C., & Blecha, F. (2005) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2005.06.004 · Cited by 67
Pietrangelo, A., & Trautwein, C. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0019 · Cited by 70
“and hepatic iron deposition can be prevented in this model by hepcidin overexpression”
BackgroundIron homeostasis: new players, newer insights
Edison, E. S., Bajel, A. R., & Chandy, M. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01143.x · Cited by 88
“It is postulated that HFE interacts with a protein in a signal transduction pathway that stimulates hepcidin (84,85).”
BackgroundCis and trans regulation of hepcidin expression by upstream stimulatory factor
Bayele, H. K., McArdle, H. J., & Srai, S. K. (2006) · Blood · doi:10.1182/blood-2005-07-027037 · Cited by 67
“On the other hand, transgenic mice that constitutively expressed hepcidin were severely anaemic thereby suggesting a role for this peptide in preventing iron-overload.(13,14) A frame-shift mutation identified in the human hepcidin gene has also been associated with a juvenile form of haemochromatosis.”
BackgroundHepcidin and its therapeutic potential in neurodegenerative disorders
Qian, Z., & Ke, Y. (2019) · Medicinal Research Reviews · doi:10.1002/med.21631 · Cited by 65
“Transgenic overexpression of hepcidin prevented iron overload and improved erythropoiesis in a β‐thalassemia mouse model(239) or hemochromatosis.(240) Also, it has been reported that elevated hepcidin, induced by genetic disruption of the hepcidin regulator TMPRSS6 (a transmembrane serine protease 6/matriptase‐2), cou…”
BackgroundPathophysiology of Hereditary Hemochromatosis
Fleming, R. E., Britton, R. S., Waheed, A., Sly, W. S., & Bacon, B. R. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-923313 · Cited by 76
Iron Pathophysiology in Alzheimer’s Diseases
Wang, T., Xu, S.-F., Fan, Y.-G., Li, L.-B., & Guo, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_5 · Cited by 64
CHEN, B., Li, G., Shen, Y., Huang, X., & Xu, Y. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2484 · Cited by 68
“Furthermore, constitutive activation of hepcidin expression or treatment with synthetic hepcidin has been demonstrated to prevent iron overload and the corresponding complications in Hfe -/- mice (39,40).”
Molecular basis of iron-loading disorders
Darshan, D., Frazer, D. M., & Anderson, G. J. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001687 · Cited by 70
Lou, D., Lesbordes, J., Nicolas, G., Viatte, L., Bennoun, M., Van Rooijen, N., Kahn, A., Renia, L., & Vaulont, S. (2005) · Hepatology · doi:10.1002/hep.20663 · Cited by 62
Self-citationIdentification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele
Biasiotto, G., Roetto, A., Daraio, F., Polotti, A., Gerardi, G. M., Girelli, D., Cremonesi, L., Arosio, P., & Camaschella, C. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2004.08.002 · Cited by 62
Catapano, A., Cimmino, F., Petrella, L., Pizzella, A., D’Angelo, M., Ambrosio, K., Marino, F., Sabbatini, A., Petrelli, M. D., Paolini, B., et al. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109888 · Cited by 77
Camacho, A. B., Simão, M., Ea, H., Cohen-Solal, M. E., Richette, P., Branco, J., & Cancela, M. L. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.09.007 · Cited by 66
Revisiting Hereditary Hemochromatosis: Current Concepts and Progress
Yen, A. W., Fancher, T. L., & Bowlus, C. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.041 · Cited by 58
Ludwiczek, S., Theurl, I., Artner-Dworzak, E., Chorney, M., & Weiss, G. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0542-3 · Cited by 57
“On the one hand recent data from mice underscore previous observations pointing to the importance of hepcidin for the regulation of body iron absorption [11, 57, 58, 59].”
BackgroundBardou‐Jacquet, E., Philip, J., Lorho, R., Ropert, M., Latournerie, M., Houssel‐Debry, P., Guyader, D., Loréal, O., Boudjéma, K., & Brissot, P. (2013) · Hepatology · doi:10.1002/hep.26570 · Cited by 57
“However, we were able to measure serum hepcidin, which exerts a primary regulatory role in iron metabolism and in hemochromatosis expression.(33,34) This provided a more precise, relevant evaluation of LT outcome.”
MethodResultChapter 6 Iron Homeostasis and Erythropoiesis
Wrighting, D. M., & Andrews, N. C. (2008) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(07)00006-3 · Cited by 69
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis
Bozzini, C., Campostrini, N., Trombini, P., Nemeth, E., Castagna, A., Tenuti, I., Corrocher, R., Camaschella, C., Ganz, T., Olivieri, O., et al. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.10.001 · Cited by 65
Pietrangelo, A. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111226 · Cited by 74
Iron Imports. VI. HFE and regulation of intestinal iron absorption
Fleming, R. E., & Britton, R. S. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00486.2005 · Cited by 62
“Moreover, crossing HFE knockout mice with mice overexpressing hepcidin leads to normalization their iron overload phenotype (26).”
BackgroundTransgenic HFE‐dependent induction of hepcidin in mice does not require transferrin receptor‐2
Schmidt, P. J., & Fleming, M. D. (2012) · American Journal of Hematology · doi:10.1002/ajh.23173 · Cited by 58
“Discussion HFE, TFR2, and b2M are necessary for the normal regulation of hepcidin production in hepatocytes [9,10,31,35,36], but the role each plays is not completely understood.”
BackgroundIron absorption by healthy women is not associated with either serum or urinary prohepcidin
Hadley, K. B., Johnson, L. K., & Hunt, J. R. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.150 · Cited by 56
“Hepcidin has been proposed to function as a key regulator of iron absorption in response to body iron stores (1–4) and requirements for erythropoiesis (2, 3, 5).”
Ramos, P., Guy, E. C., Chen, N., Proenca, C. C., Gardenghi, S., Casu, C., Follenzi, A., van Rooijen, N., Grady, R. W., de Sousa, M. A. B., et al. (2010) · Blood · doi:10.1182/blood-2010-09-307462 · Cited by 58
Hepcidin: another culprit for complications in patients with chronic kidney disease?
Nakanishi, T., Hasuike, Y., Otaki, Y., Kida, A., Nonoguchi, H., & Kuragano, T. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr410 · Cited by 54
“In addition, constitutive expression of hepcidin has been shown to prevent iron overload in HFE knockout mice [21].”
BackgroundIron absorption in male C282Y heterozygotes
Roe, M. A., Heath, A. M., Oyston, S. L., Macrow, C., Hoogewerff, J. A., Foxall, R., Dainty, J. R., Majsak‐Newman, G., Willis, G. A., & Fairweather‐Tait, S. J. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.4.814 · Cited by 57
Molecular insights into the pathogenesis of hereditary haemochromatosis
Pietrangelo, A. (2006) · Gut · doi:10.1136/gut.2005.078063 · Cited by 60
Exploiting natural peptide diversity: novel research tools and drug leads
Adermann, K., John, H., Ständker, L., & Forssmann, W. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.10.007 · Cited by 51
Yun, S., & Vincelette, N. D. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.02.006 · Cited by 62
“[40] Nicolas G, Viatte L, Lou DQ, et al.”
BackgroundCrosstalk between Iron Metabolism and Erythropoiesis
Li, H., & Ginzburg, Y. Z. (2010) · Advances in Hematology · doi:10.1155/2010/605435 · Cited by 53
“the increased iron absorption in the duodena of H f e−/− mice [101] and forced expression of hepcidin corrects the hemochromatosis phenotype [83].”
BackgroundControl of Systemic Iron Homeostasis by the Hemojuvelin-Hepcidin Axis
Zhang, A. (2010) · Advances in Nutrition · doi:10.3945/an.110.1009 · Cited by 51
“Conversely, inappropriately increased hepcidin expression causes severe iron deficiency anemia in humans (10) and mice (11).”
BackgroundHepcidin, a candidate modifier of the hemochromatosis phenotype in mice
Nicolas, G., Andrews, N. C., Kahn, A., & Vaulont, S. (2003) · Blood · doi:10.1182/blood-2003-09-3358 · Cited by 48
Molecular basis of HFE-hemochromatosis
Vujić, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00042 · Cited by 58
“…levels present in Hfe−/− mice were significantly reduced by hepcidin treatments, without affecting hepatic iron load which remained inappropriately high in regard to hepcidin levels (Nicolas et al., 2003; Laftah et al., 2004; Rivera et al., 2005; Viatte et al., 2006; Moran-Jimenez et al., 2010).”
BackgroundIron metabolism in the eye: A review
Goralska, M., Ferrell, J., Harned, J., Lall, M. M., Nagar, S., Fleisher, L. N., & McGahan, M. C. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.10.026 · Cited by 56
“This was confirmed in a number of studies and is an interesting control mechanism (Bridle et al. 2003; Muckenthaler et al. 2003; Nicolas et al. 2003).”
BackgroundAdvances in understanding the molecular basis for the regulation of dietary iron absorption
Fleming, R. E. (2005) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000153362.98276.db · Cited by 60
Analyses for binding of the transferrin family of proteins to the transferrin receptor 2
Kawabata, H., Tong, X., Kawanami, T., Wano, Y., Hirose, Y., Sugai, S., & Koeffler, H. P. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05224.x · Cited by 44
“Mutations of HFE (Feder et al, 1996), hepcidin (HAMP; hepatic anti-microbial peptide) (Roetto et al, 2003), HFE2/ HJV (hemojuvelin) (Papanikolaou et al, 2003) and TfR2 (Camaschella et al, 2000) genes cause a similar phenotype of HH, suggesting that the products of these genes share a common pathway…”
BackgroundNairz, M., Schroll, A., Haschka, D., Dichtl, S., Tymoszuk, P., Demetz, E., Moser, P., Haas, H., Fang, F. C., Theurl, I., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00110 · Cited by 46
“This interaction controls cellular iron acquisition while also modifying the expression of the key iron-regulatory hormone Hamp (Ahmad et al., 2002; Nicolas et al., 2003; Ludwiczek et al., 2005; Vujic Spasic et al., 2008).”
BackgroundModulation of Hepcidin as Therapy for Primary and Secondary Iron Overload Disorders
Schmidt, P. J., & Fleming, M. D. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.004 · Cited by 44
“3B) greatly decreased iron loading in whole embryos and also in the livers of 1- and 2-month-old HH animals.(36) In fact, in many animals, the correction of the hepcidin deficiency was too great, leading to”
BackgroundKowdley, K. V., Modi, N. B., Peltekian, K. M., Vierling, J. M., Ferris, C. D., Valone, F. H., & Gupta, S. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00250-9 · Cited by 42
Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology
Vela, D. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.111 · Cited by 42
Molecular analysis of iron overload in β2-microglobulin-deficient mice
Muckenthaler, M. U., Rodrigues, P., Macedo, M. G., Miñana, B., Brennan, K., Cardoso, E. M., Hentze, M. W., & de Sousa, M. A. B. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2004.05.003 · Cited by 46
“Moreover, Hfe-deficient mice interbred with hepcidin-expressing transgenic mice are protected from iron accumulation in the liver [22].”
BackgroundTransferrin receptor 1 mRNA is downregulated in placenta of hepcidin transgenic embryos
Martin, M. E., Nicolas, G., Hetet, G., Vaulont, S., Grandchamp, B., & Beaumont, C. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.08.010 · Cited by 40
Galesloot, T. E., Geurts-Moespot, A. J., den Heijer, M., Sweep, F. C. G. J., Fleming, R. E., Kiemeney, L. A. L. M., Vermeulen, S. H. H. M., & Swinkels, D. W. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101673 · Cited by 39
Hepcidin and its role in iron absorption
Robson, K. J. H. (2004) · Gut · doi:10.1136/gut.2003.027631 · Cited by 39
Fisher, A. L., & Babitt, J. L. (2021) · Developmental Dynamics · doi:10.1002/dvdy.372 · Cited by 43
Iron Stores Modulate Hepatic Hepcidin Expression by an HFE-Independent Pathway
Gehrke, S. G., Herrmann, T. R. W., Kulaksiz, H., Merle, U., Bents, K., Kaiser, I., Riedel, H.-D., & Stremmel, W. (2005) · Digestion · doi:10.1159/000087400 · Cited by 37
Hepcidin and Iron Metabolism in Experimental Liver Injury
Bloomer, S. A., & Brown, K. E. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.04.005 · Cited by 38
“Expression of a hepcidin transgene reverses the iron overload phenotype of Hfe mice.(23) Complete or conditional knockout of Tfr2 results in increases in hepatic iron, ranging from approximately twofold to >20-fold compared with wild-type controls.”
BackgroundAndrews, N. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmcibr1112780 · Cited by 36
Mécanismes moléculaires de l’homéostasie du fer
Beaumont, C. (2004) · médecine/sciences · doi:10.1051/medsci/200420168 · Cited by 39
“Cette hypothèse a été renforcée par la mise en évidence, chez la souris [26] comme chez l’homme [27], d’un défaut d’activation de la synthèse d’hepcidine en réponse à une surcharge en fer lorsque la protéine HFE est mutée ou inactivée.”
Livesey, K., Wimhurst, V. L. C., Carter, K., Worwood, M., Cadet, E., Rochette, J., Roberts, A. G., Pointon, J. J., Merryweather-Clarke, A. T., Bassett, M. L., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.008805 · Cited by 40
Neutrophils from hereditary hemochromatosis patients are protected from iron excess and are primed
Renassia, C., Louis, S., Cuvellier, S., Boussetta, N., Deschemin, J., Borderie, D., Bailly, K., Poupon, J., Dang, P. M., Benna, J. E., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002198 · Cited by 36
Dietary iron regulates hepatic hepcidin 1 and 2 mRNAs in mice
Mazur, A., Feillet‐Coudray, C., Romier, B., Bayle, D., Gueux, E., Ruivard, M., Coudray, C., & Rayssiguier, Y. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00277-4 · Cited by 36
Systemic Regulation of Intestinal Iron Absorption
Steele, T. M., Frazer, D. M., & Anderson, G. J. (2005) · IUBMB Life · doi:10.1080/15216540500149904 · Cited by 41
Animal Models of Normal and Disturbed Iron and Copper Metabolism
Wang, X., Garrick, M. D., & Collins, J. F. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz172 · Cited by 37
“, in Hbbth-1/th-1 and Hbbth-3/+ mice) demonstrated that transgenic overexpression of hepcidin prevents iron overload and improves erythropoiesis (107, 108).”
BackgroundRegulation of Iron Absorption in Hemoglobinopathies
Rechavi, G., & Rivella, S. (2008) · Current Molecular Medicine · doi:10.2174/156652408786241401 · Cited by 32
Advances in iron chelation therapy: transitioning to a new oral formulation
Shah, N. (2017) · Drugs in Context · doi:10.7573/dic.212502 · Cited by 35
“Studies in mouse models have shown that an artificial increase in hepcidin expression prevents hemochromatosis in thalassemia and other anemias that are complicated by secondary iron overload while decreased hepcidin production leads to increased iron absorption thereby increasing the iron burden of transfusion therap…”
BackgroundHepcidin protects against iron overload-induced inhibition of bone formation in zebrafish
Jiang, Y. Y., Chen, B., Yan, Y., & Zhu, G. (2018) · Fish Physiology and Biochemistry · doi:10.1007/s10695-018-0568-z · Cited by 35
West, A. R., & Oates, P. S. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05047.x · Cited by 33
Oxidative folding of hepcidin at acidic pH
Zhang, J., Diamond, S., Arvedson, T., Sasu, B. J., & Miranda, L. P. (2010) · Biopolymers · doi:10.1002/bip.21383 · Cited by 33
Alterações moleculares associadas à hemocromatose hereditária
Santos, P. C. J. L., Cançado, R. D., Terada, C. T., & Guerra‐Shinohara, E. M. (2009) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842009005000051 · Cited by 53
Inherited iron loading: genetic testing in diagnosis and management
Worwood, M. (2004) · Blood Reviews · doi:10.1016/j.blre.2004.03.003 · Cited by 35
UBA6 and NDFIP1 regulate the degradation of ferroportin
Traeger, L., Wiegand, S. B., Sauer, A. J., Corman, B. H. P., Peneyra, K. M., Wunderer, F., Fischbach, A., Bagchi, A., Malhotra, R. K., Zapol, W. M., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.278530 · Cited by 31
Recombinant human hepcidin expressed in Escherichia coli isolates as an iron containing protein
Gerardi, G., Biasiotto, G., Santambrogio, P., Zanella, I., Ingrassia, R., Corrado, M., Cavadini, P., Derosas, M., Levi, S., & Arosio, P. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.06.002 · Cited by 29
“Studies on animal models have demonstrated that hepcidin blocks intestinal iron absorption, macrophage iron recycling and placental iron transport [10–12].”
Review article: the genetic basis of haemochromatosis
Griffiths, W. J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03387.x · Cited by 34
Effect of penicillamine and zinc on iron metabolism in Wilson's disease
Medici, V., Leo, V. D., Lamboglia, F., Bowlus, C. L., Tseng, S.-C., Renata D'Incà, Irato, P., Burra, P., Martines, D., & Sturniolo, G. C. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701514495 · Cited by 28
“In genetic hemochromatosis, hepcidin mRNA levels are significantly reduced [11] and the forced expression of hepcidin prevents iron loading in HFE-deficient mice [12].”
BackgroundGaruti, C., Tian, Y., Montosi, G., Sabelli, M., Corradini, E., Graf, R., Ventura, P., Vegetti, A., Clavien, P., & Pietrangelo, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.043 · Cited by 28
The Emerging Role of the Liver in Iron Metabolism
Sharma, N., Butterworth, J. R., Cooper, B. T., Tselepis, C., & Iqbal, T. H. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40152.x · Cited by 31
“Furthermore, HFE knock-out mice with constitutive expression of hepcidin resulted in the reversal of a hemochromatosis phenotype (31).”
BackgroundRecent advances in intestinal iron transport
Anderson, G. J., & Frazer, D. M. (2005) · Current Gastroenterology Reports · doi:10.1007/s11894-005-0005-1 · Cited by 32
Liver-gut axis in the regulation of iron homeostasis
Darshan, D., & Anderson, G.-J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4737 · Cited by 40
Liu, J., Liu, W., Liu, Y., Miao, Y., Guo, Y., Song, H., Wang, F., Zhou, H., Ganz, T., Yan, B., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.209874 · Cited by 30
Wang, C., Fang, Z., Zhu, Z., Liu, J., & Chen, H. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.05.002 · Cited by 30
Vaulont, S., Lou, D.-Q., Viatte, L., & Kahn, A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25642 · Cited by 26
Kelleher, T., Ryan, E., Barrett, S., Sweeney, M., Byrnes, V, O’Keane, C., & Crowe, J. (2004) · Gut · doi:10.1136/gut.2003.033811 · Cited by 24
Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection
Ghaziani, T., Alavian, S. M., Zali, M. R., Shahraz, S., Agah, M. R., Jensen, K. P., Ansari, S., Sendi, H., Lambrecht, R. W., Covault, J., et al. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00026.x · Cited by 22
Schmidt, P. J., Andrews, N. C., & Fleming, M. D. (2010) · Blood · doi:10.1182/blood-2010-04-277954 · Cited by 23
Nahdi, A., Hammami, I., Brasse‐Lagnel, C., Pilard, N., Hamdaoui, M. H., Beaumont, C., & May, M. E. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.01.004 · Cited by 23
“Iron homeostasis is mainly regulated by hepcidin, a peptide secreted by the liver in response to iron loading [4,5] and inflammation [6].”
BackgroundHDAC1 governs iron homeostasis independent of histone deacetylation in iron-overload murine models
Yin, X., Wu, Q., Monga, J., Xie, E., Wang, H., Wang, S., Zhang, H., Wang, Z.-Y., Zhou, T., Shi, Y., et al. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7161 · Cited by 22
“Unlike strategies designed to increase hepcidin levels [ e.g. , using either transgenic hepcidin mice (31, 47) or a synthesized minihepcidin peptide (5, 36)], entinostat had no effect on serum iron or splenic nonheme iron content (Supplementary Fig.”
A chemical screen identifies small molecules that regulate hepcidin expression
Gaun, V., Patchen, B., Volovetz, J., Zhen, A. W., Andreev, A., Pollastri, M. P., & Fraenkel, P. G. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.06.002 · Cited by 22
“Intriguingly, transgenic over-expression of Hepcidin in mouse models of hereditary hemochromatosis[13] or β-thalassemia [14] reduces iron overload.”
BackgroundHepcidin as a therapeutic target in iron overload
Sandnes, M., & Reikvam, H. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2443081 · Cited by 27
“In 2003, a murine model of HFE-hemochromatosis first demonstrated that hepcidin overexpression effectively prevented iron overload [27].”
Iron Pathophysiology in Stroke
Almutairi, M. M., Xu, G., & Shi, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_6 · Cited by 22
Molecular regulation of hepatic expression of iron regulatory hormone hepcidin
Oates, P. S., & Ahmed, U. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04950.x · Cited by 25
Stoichiometries of transferrin receptors 1 and 2 in human liver
Chloupková, M., Zhang, A.-S., & Enns, C. A. (2009) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2009.09.004 · Cited by 23
“The discovery that hepcidin, an iron regulatory hormone predominantly expressed in hepatocytes [17], is decreased in both HH type 1 patients [18] and Hfe-/- mice [19;20] and that HFE is also predominantly expressed in hepatocytes [21] indicated that the primary site of HFE effects on iron homeostasis is the liver.”
BackgroundRecent Developments in Liver Pathology
Yan, B. C., & Hart, J. A. L. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.7.1078 · Cited by 22
Serum Prohepcidin and Hepcidin in Hemodialyzed Patients Undergoing Iron Therapy
Małyszko, J., Małyszko, J. S., & Myśliwiec, M. (2009) · Kidney & Blood Pressure Research · doi:10.1159/000235747 · Cited by 18
Scotet, V., Gac, G. L., Mérour, M.-C., Mercier, A., Chanu, B., Ka, C., Mura, C., Nousbaum, J., & Férec, C. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-24 · Cited by 22
“This pathology displays a large genetic heterogeneity because several other types of hemochromatosis, associated with different genes and patterns of inheritance, have been reported [1]: HH type 2B is a juvenile form linked to the HAMP gene (encoding for hepcidin) [2-4], HH type 3 is linked to the TfR2 gene (encoding…”
BackgroundScreening for hemochromatosis: Patients with liver disease, families, and populations
Galhenage, S., Viiala, C. H., & Olynyk, J. K. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0025-2 · Cited by 19
“Hepcidin overexpression prevented iron overload in a mouse HFE1 model [ 28 ].”
BackgroundIron-independent specific protein expression pattern in the liver of HFE-deficient mice
Petrák, J., Myslivcová, D., Halada, P., Čmejla, R., Čmejlová, J., Vyoral, D., & Vulpe, C. D. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.01.021 · Cited by 18
Gong, R., An, Z., Zhang, W., Chen, F., & Wang, K. (2022) · Marine Drugs · doi:10.3390/md20100651 · Cited by 17
“Several studies in animal models have shown that restoring appropriate hepcidin levels can be used to treat iron-dysregulation diseases, such as hereditary hemochromatosis and iron-refractory iron deficiency anemia [19,20].”
BackgroundDonnées récentes sur le métabolisme du fer : un état de transition
Cadet, E., Gadenne, M., Capron, D., & Rochette, J. (2004) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2004.09.024 · Cited by 28
The role of heparin, heparanase and heparan sulfates in hepcidin regulation
Asperti, M., Denardo, A., Gryzik, M., Arosio, P., & Poli, M. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.008 · Cited by 18
Hemojuvelin: a supposed role in iron metabolism one year after its discovery
Celec, P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0668-y · Cited by 17
“HFE knockout mice have higher hepatic iron levels, if lacking one hepcidin allele in comparison withHFE hepcidin mice [38].”
Background
Metadata
- Authors
- Nicolas, G., Viatte, L., Lou, D.-Q., Bennoun, M., Beaumont, C., Kahn, A., Andrews, N. C., & Vaulont, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Vaulont, Sophie
- Venue
- Nature Genetics
- Published
- 2003-04-21
- Volume
- 34
- Issue
- 1
- Pages
- 97-101
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2018391935
- Cited by
- 311
- References
- 25
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 2 · 2021: 6 · 2020: 6 · 2019: 11 · 2018: 7 · 2017: 9 · 2016: 10 · 2015: 7 · 2014: 8 · 2013: 11 · 2012: 8
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hereditary hemochromatosis, hepcidin, HFE gene, Hfe knockout mice, iron overload, hyperferremia, hepatic iron deposition, intestinal iron absorption, reticuloendothelial cells, iron homeostasis
- MeSH terms
- Hemochromatosis Protein, Animals, Crosses, Genetic, Hemochromatosis, Humans, Membrane Proteins, Mice, Transgenic, Phenotype, RNA, Messenger, Histocompatibility Antigens Class I, Gene Expression, Mice, Knockout, Iron Overload, Mutation, Missense, Antimicrobial Cationic Peptides, Mice, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.